Order Article Reprints

Delgado-Maldonado T, González-González A, Moreno-Rodríguez A, Bocanegra-García V, Martinez-Vazquez AV, de Luna-Santillana EdJ, Pujadas G, Rojas-Verde G, Lara-Ramírez EE, Rivera G. Ligand- and Structure-Based Virtual Screening Identifies New Inhibitors of the Interaction of the SARS-CoV-2 Spike Protein with the ACE2 Host Receptor. Pharmaceutics. 2024; 16(5):613. https://doi.org/10.3390/pharmaceutics16050613

Delgado-Maldonado, Timoteo, Alonzo González-González, Adriana Moreno-Rodríguez, Virgilio Bocanegra-García, Ana Verónica Martinez-Vazquez, Erick de Jesús de Luna-Santillana, Gerard Pujadas, Guadalupe Rojas-Verde, Edgar E. Lara-Ramírez, and Gildardo Rivera. 2024. "Ligand- and Structure-Based Virtual Screening Identifies New Inhibitors of the Interaction of the SARS-CoV-2 Spike Protein with the ACE2 Host Receptor" Pharmaceutics 16, no. 5: 613. https://doi.org/10.3390/pharmaceutics16050613

Delgado-Maldonado, T., González-González, A., Moreno-Rodríguez, A., Bocanegra-García, V., Martinez-Vazquez, A. V., de Luna-Santillana, E. d. J., Pujadas, G., Rojas-Verde, G., Lara-Ramírez, E. E., & Rivera, G. (2024). Ligand- and Structure-Based Virtual Screening Identifies New Inhibitors of the Interaction of the SARS-CoV-2 Spike Protein with the ACE2 Host Receptor. Pharmaceutics, 16(5), 613. https://doi.org/10.3390/pharmaceutics16050613